For Q4FY18, Caplin Point Laboratories reported 21.5% yoy growth in the revenue to Rs143.4cr vs. Rs118.3cr in Q4FY17. EBITDA grew by 12.7% yoy to Rs48.7cr vs. Rs43.2cr in Q4FY17. EBITDA margins in Q4FY18 were at 34% vs 36.6% in Q4FY17 and 35.9% in Q3FY18. PAT grew by 5.9% yoy to Rs35.3cr vs Rs33.3cr in Q4FY17.
Gross margin stood at 56.6% in Q4FY18 vs 53.8% in Q3FY18 and 57.2% in Q4FY17.
Material cost increased by 23% yoy to Rs62.2cr during the quarter. There was ~53bps yoy increase in the material cost as percentage of sales in Q4FY18.
Employee cost grew by 23.8% yoy to Rs10.1cr, as percentage of sales, employee cost increased marginally by 13bps yoy.
Other expenses grew by 39.2% yoy to Rs22.4cr and as percentage of sales, other expenses increased by ~198bps, which led to decline in the EBITDA margins.
Caplin Point Laboratories Ltd is currently trading at Rs538.05, down by 57.25 points or 9.62% from its previous closing of Rs595.30 on the BSE. The scrip opened at Rs589.20 and has touched a high and low of Rs594.70 and Rs512.70 respectively. So far 4,30,782 (NSE+BSE) shares were traded on the counter. The stock is currently trading above its 200 DMA.
Please use the temporary password sent on your email id or mobile no.
Update Mobile no.
Why you need to update your Mobile number ?
By providing verified mobile number we provide more exclusive information in the website.
Update Mobile no.
Terms & Conditions
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in National Do Not Call Registry as laid down by Telecom Regulatory Authority of India will not be applicable for such information/ communication.